Title Journal Title, Volume, Page Full Text Year of Publicationsort icon
Prescribing Pattern of Angiotensin- Converting Enzyme Inhibitors ‎and Beta Blockers After Acute Myocardial Infarction Saudi Med J. ;26(11):1837-9 2005
Drug Informational Value of Patient Package Insert (PPI): A Sample Study in Palestine Journal of the Islamic University of Gaza, (Natural Sciences Series) Vol.12, No.2, PP. 59-68 2004
Design, Synthesis, and Biological Evaluation of New 8-‎Heterocyclic Xanthine Derivatives As Highly Potent And Selective ‎Human A2B Adenosine Receptor Antagonists J. Med. Chem. 47:1434-1447 2004
A Synthetic Approach for the Preparation of Rigid Analogs of 1,3-Dipropyl-7-methyl-8-aryl/heteroarylstyryl Xanthines Synthesis (5): 0773-0777 2001
Synthesis and Biological Effects of a New Series of 2-Amino-3-Benzoylthiophenes as Allosteric ‎Enhancers of A1-Adenosine Receptor Bioorganic & Medicinal Chemistry Letters Volume 10, Issue 17, Pages 1953–1957 2000
DNA Minor-Groove Binders: Results and Design of New Antitumor Agents FARMACO Volume: 54 Issue: 1-2 Pages: 15-25 Published: JAN-FEB 1999 1999
Synthesis and Anti HSV-1 Activity of 6 Substituted Pyrazole [3,4-D] Pyridazine -7-we Nucleosides Nucleosides & Nucleotides .17.(12),2165-2173 1998
Heterocyclic Analogs of DNA Minor Groove Alkylating Agents Curr Pharm Des.;4(3):249-76. 1998
A New Synthetic Approach to Indazoles Synthesis Synthesis ; 1997(10): 1140-1142 1997
Synthesis, Solvolytic Stability and Cytotoxicity of a Modified ‎Derivative of CPzI, a Pyrazole Analog of the Alkylation Subunit ‎of the Antitumor Agent CC-1065: Effect of the Nitrogen ‎Substitution on the Functional Reactivity II Farmaco 52, 717-723 1997
Synthesis, Cytotoxicity and Antitumor Activity of Some New Simplified ‎Pyrazole Analogs of the Antitumor Agent CC-1065. Effect of an ‎Hydrophobic Group on Antitumor Activity II Farmaco, 52. 711-716 1997
Pyridazine Nucleus: A Pharmacophoric Moiety For Bio-Active Compounds Aphcao 66,S35-S38. 1996
Liposomes- and Ethosomes-Associated Distamycins: A ‎Comparative Study
Vulnerability of Cough Syrups Marketed In Palestine to Microbial Challenge Test